Rennes University Hospital
| Centre hospitalier universitaire de Rennes | |
|---|---|
 Main building of the Hospital Pontchaillou | |
| Geography | |
| Location | France |
| Coordinates | 48°07′15″N 1°41′47″W / 48.12083°N 1.69637°WCoordinates: 48°07′15″N 1°41′47″W / 48.12083°N 1.69637°W |
| Organisation | |
| Hospital type | University Hospital |
| Services | |
| Emergency department | Yes |
| Links | |
| Website |
www |
The Rennes University Hospital (French: Centre hospitalier universitaire de Rennes or CHU Rennes) is a university hospital in Rennes in France. It employs 7,700 people[1] and processes nearly 1,500 hospitalisations per day. It was the second largest employer in the Rennes region.[2] It is one of 42 French hospital equipped with the da Vinci Surgical System.
In 2014, the Rennes University Hospital was ranked in the top 10 hospitals in France.[3]
Research
Research at CHU Rennes has included a study of the efficacy of nalmefene.[4][5]
In 2016, a facility run by the private contract research organization Biotrial, running clinical trials required patients to be admitted to CHU Rennes.[6] The facility ran a phase one study into a new drug being developed by Bial that targets the human endocannabinoid system.[7] The study failed catastrophically, leaving six subjects hospitalized and one brain dead.[8][9]
See also
References
- ↑ Chiffres clefs 2007, www.chu-rennes.fr
- ↑ Le pays de Rennes, INSEE, p. 113.
- ↑ Le Point, magazine. "Hôpitaux - L'actualité Santé – Le Point".
- ↑ "Study questions drug for alcohol cravings". news.
- ↑ "PLOS Medicine".
- ↑ "Rennes. Biotrial, un acteur important des essais thérapeutiques". Ouest-France.fr.
- ↑ Lizzie Dearden (15 January 2016). "France clinical trial: Prosecutors investigating 'accident' as Biotrial defends drug testing safety record". The Independent.
- ↑ "DIRECT- Accident thérapeutique à Rennes : les patients sont de l'Ouest". Ouest-France.fr.
- ↑ "6 Hospitalized, One of Them Brain-Dead, After Drug Trial in France". The New York Times. 16 January 2016.